Elana Gazal
Chief Tech/Sci/R&D Officer at COLLPLANT BIOTECHNOLOGIES LTD.
Net worth: - $ as of 31/03/2024
Profile
Elana Gazal is currently the Vice President of Research & Development at CollPlant Biotechnologies Ltd.
Prior to this, she was the Head of Pharmaceutical Research at NeuroDerm Ltd.
from 2017 to 2022.
Dr. Gazal holds a doctorate degree from The Hebrew University of Jerusalem.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Elana Gazal active positions
| Companies | Position | Start |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Former positions of Elana Gazal
| Companies | Position | End |
|---|---|---|
| NEURODERM LTD | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Training of Elana Gazal
| The Hebrew University of Jerusalem | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| Private companies | 1 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Elana Gazal
